Overview of Microvascular Angina Pectoris and Discussion of Traditional Chinese Medicine Intervention
- PMID: 35035497
- PMCID: PMC8754603
- DOI: 10.1155/2022/1497722
Overview of Microvascular Angina Pectoris and Discussion of Traditional Chinese Medicine Intervention
Abstract
Previous research and treatment of coronary heart disease mostly focused on the large epicardial vessels, with limited research on the small endocardial coronary arteries or arterioles that could not be detected by coronary angiography, especially microvascular angina caused by microvascular stenosis or microcirculation dysfunction. Conventional Western medicine therapies have no specific efficacy, but traditional Chinese medicine has significant advantages in this regard. In particular, traditional Chinese medicine of supplementing Qi and activating blood circulation protects the vascular endothelium, relaxes coronary microvessels, reduces myocardial no-reflow after ischemia-reperfusion, increases myocardial hypoxia tolerance, constrains the aggregation of platelet, and increases the rate of blood flow. Moreover, these treatments can significantly improve patients' symptoms through multitarget comprehensive intervention. Here, we analyzed the pathogenesis of microvascular angina pectoris, the treatment status of modern medicine, and the research on the multitarget intervention of traditional Chinese medicine to provide new research ideas for correctly identifying the role of coronary microcirculation in coronary artery disease to solve clinical problems and prevent cardiovascular events.
Copyright © 2022 Linghua Yu et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway.J Ethnopharmacol. 2020 Oct 28;261:113069. doi: 10.1016/j.jep.2020.113069. Epub 2020 Jun 30. J Ethnopharmacol. 2020. PMID: 32619593
-
Reappraisal of Ischemic Heart Disease.Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373. Circulation. 2018. PMID: 30354347 Review.
-
Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms.J Am Coll Cardiol. 1998 Mar 1;31(3):541-6. doi: 10.1016/s0735-1097(97)00542-1. J Am Coll Cardiol. 1998. PMID: 9502632
-
Angina pectoris caused by coronary microvascular spasm.Lancet. 1998 Apr 18;351(9110):1165-9. doi: 10.1016/S0140-6736(97)07329-7. Lancet. 1998. PMID: 9643687
-
Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunction.Vasc Med. 2017 Apr;22(2):146-160. doi: 10.1177/1358863X16686410. Vasc Med. 2017. PMID: 28429664 Review.
Cited by
-
Gender Disparities in Patients' Decisions about the Management of Myocardial Infarction in East Chinese Province.Emerg Med Int. 2023 Dec 6;2023:8220308. doi: 10.1155/2023/8220308. eCollection 2023. Emerg Med Int. 2023. PMID: 38099235 Free PMC article.
-
Yangxin decoction for the treatment of angina pectoris of coronary heart disease: A systematic review of randomized controlled trial.Medicine (Baltimore). 2022 Sep 2;101(35):e30394. doi: 10.1097/MD.0000000000030394. Medicine (Baltimore). 2022. PMID: 36107541 Free PMC article.
References
-
- Li J., Xu H., Shi D. Randomized controlled clinical study of integrated traditional Chinese and Western medicine in coronary heart disease: progress and prospect. Chinese Journal of Integrated Traditional Chinese and Western Medicine . 2017;37(5):517–521.
-
- Jacob R., Bachmann T. C., Merete H., et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. European Heart Journal . 2019;40(18):1426–1435. - PubMed
-
- Narbeh M., De Bruyne B., Fearon W. F, MacCarthy P. A. The pathophysiology and clinical course of the normal coronary angina syndrome (cardiac syndrome X) Progress in Cardiovascular Diseases . 2008;50(4) - PubMed
-
- Zhang Y. Mechanism and Intervention of Coronary Slow Flow Microcirculation Disorder . Shangai, China: Naval Military Medical University of the Chinese people’s Liberation Army; 2021.
Publication types
LinkOut - more resources
Full Text Sources
